The cell cycle is a tightly regulated sequence of events that results in the duplication of cellular contents and division into two daughter cells. Its proper regulation is essential for development, tissue homeostasis, and the prevention of cancer.
Phases of the Cell Cycle
Interphase comprises three phases: G₁ (Gap 1), S (Synthesis), and G₂ (Gap 2), and cells spend most of their time in interphase preparing for division. During G₁ phase, the cell grows, synthesizes RNA and proteins, and monitors environmental conditions; growth factor signaling promotes progression through this phase. S phase involves DNA replication, producing two identical sister chromatids per chromosome, with each centromere duplicated and histone proteins synthesized to package newly replicated DNA. In G₂ phase, continued growth and preparation for mitosis occur, along with checking for complete and accurate DNA replication. M phase (Mitosis) encompasses chromosome segregation and cell division, including prophase, prometaphase, metaphase, anaphase, telophase, and cytokinesis. G₀ phase is a quiescent state entered by cells that are not actively cycling (e.g., mature neurons, hepatocytes), though these cells can re-enter G₁ upon appropriate stimulation.
Cyclins and Cyclin-Dependent Kinases
CDKs (CDK1, CDK2, CDK4, CDK6) are serine/threonine kinases that drive cell cycle progression when bound to cyclin regulatory subunits. Cyclin D (D1, D2, D3) is synthesized in response to growth factors and forms complexes with CDK4/6 to drive G₁ progression by phosphorylating Rb. Cyclin E peaks at the G₁/S transition; cyclin E-CDK2 completes Rb phosphorylation and promotes S phase entry. Cyclin A activates CDK2 in S phase (DNA replication) and CDK1 in G₂ (mitotic preparation). Cyclin B binds CDK1 to form the maturation-promoting factor (MPF), which drives entry into mitosis, and is degraded by APC/C at anaphase onset.
Cell Cycle Checkpoints
The G₁ checkpoint (restriction point in mammals) assesses growth factors, nutrient availability, and DNA integrity — passage commits the cell to division, and the p53-Rb pathway is critical here. The G₂/M checkpoint ensures complete DNA replication and checks for DNA damage before mitotic entry, with ATM/ATR-Chk1/Chk2 signaling delaying the cycle if damage is detected. The spindle assembly checkpoint (SAC) monitors proper attachment of microtubules to kinetochores during metaphase and prevents anaphase onset until all chromosomes are correctly attached.
Retinoblastoma Protein (Rb) and E2F
Rb is a tumor suppressor that controls the G₁/S transition. Hypophosphorylated Rb binds E2F transcription factors, repressing S phase gene expression. Cyclin D-CDK4/6 initiates Rb phosphorylation, and cyclin E-CDK2 hyperphosphorylates Rb, releasing E2F. Free E2F then activates genes for DNA replication, including DNA polymerase, PCNA, and thymidine kinase. Loss of Rb function (by mutation or HPV E7 oncoprotein) leads to constitutive E2F activity and uncontrolled proliferation, contributing to cancer.
p53 Tumor Suppressor
p53 is the guardian of the genome, activated by DNA damage, oncogene activation, and hypoxia, and is the most frequently mutated gene in human cancers. p53 activates transcription of p21 (a CDK inhibitor), which inhibits cyclin-CDK complexes, causing G₁ arrest. Other p53 targets include GADD45 (DNA repair), PUMA and Bax (apoptosis), and sestrins (antioxidant defense). In cases of severe or irreparable damage, p53 induces apoptosis through the mitochondrial pathway via Bax/Bak activation, cytochrome c release, and the caspase cascade.
Mitosis
In prophase, chromatin condenses into visible chromosomes, the mitotic spindle begins to form, and centrosomes migrate to opposite poles. During prometaphase, the nuclear envelope breaks down (lamina phosphorylation by CDK1), and microtubules penetrate the nuclear region and attach to kinetochores at centromeres. In metaphase, chromosomes align at the metaphase plate (equator), with biorientation ensuring each sister chromatid is attached to opposite poles. Anaphase involves separase cleaving cohesin, allowing sister chromatid separation (anaphase A) and spindle elongation (anaphase B), as chromosomes move toward opposite poles. In telophase, chromosomes decondense, the nuclear envelope reforms around each daughter nucleus, and the spindle disassembles. Cytokinesis follows as the contractile ring (actin and myosin II filaments) constricts at the cleavage furrow, dividing the cytoplasm, and abscission completes separation.
Meiosis
Meiosis I involves the separation of homologous chromosomes (reductional division), with prophase I including synapsis (pairing of homologs) and crossing over (genetic recombination via Holliday junctions). Meiosis II involves the separation of sister chromatids (equational division), similar to mitosis, and produces four haploid gametes. Meiotic errors such as nondisjunction cause aneuploidy (trisomy 21 in Down syndrome, monosomy X in Turner syndrome), with incidence increasing with maternal age.
Cell Cycle Dysregulation in Cancer
Oncogenic mutations in cyclins — such as cyclin D1 overexpression in breast cancer and cyclin E amplification in ovarian cancer — drive uncontrolled proliferation. CDK4/6 inhibitors (palbociclib, ribociclib, abemaciclib) are effective in hormone receptor-positive breast cancer. Loss of checkpoint function (p53 mutation, Rb loss) allows proliferation despite DNA damage, enabling accumulation of additional mutations. Telomerase reactivation in cancer prevents replicative senescence, allowing unlimited proliferation potential.
